The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of CD4 cells in the complete anti-tumor response to PD1 blockade in a syngeneic murine melanoma model with activated WNT signaling.
 
Siwen Hu-Lieskovan
Consulting or Advisory Role - Amgen; Genmab; Merck
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Nektar (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Plexxikon (Inst); Vaccinex (Inst)
 
Davis Yuri Torrejon
No Relationships to Disclose
 
Jesse Meir Zaretsky
No Relationships to Disclose
 
Jennifer Tsoi
No Relationships to Disclose
 
Gardenia Cheung-Lau
No Relationships to Disclose
 
Agustin Vega-Crespo
No Relationships to Disclose
 
Katrina Meeth
No Relationships to Disclose
 
Robert Michael Prins
No Relationships to Disclose
 
Thomas Graeber
No Relationships to Disclose
 
Marcus Besenberg
No Relationships to Disclose
 
Catherine Grasso
No Relationships to Disclose
 
Begonya Comin-Anduix
No Relationships to Disclose
 
Antoni Ribas
Stock and Other Ownership Interests - Advaxis; Arcus Biosciences; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; PACT Pharma; Tango Therapeutics
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck; Novartis